Covered recipient · General Payments record
CAESAR DEIPARINE
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2024
$1,074.53
- Reported across 62 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $206.18 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $33.20 | 2 |
| Exact Sciences Corporation | $32.26 | 2 |
| ABBVIE INC. | $24.69 | 1 |
| GENZYME CORPORATION | $24.27 | 1 |
| PFIZER INC. | $19.85 | 1 |
| Novo Nordisk AS | $19.36 | 1 |
| Lilly USA, LLC | $19.31 | 1 |
| DEXCOM, INC. | $18.73 | 1 |
| Astellas Pharma US Inc | $14.51 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.69 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103619292 | CMS |
| Astellas Pharma US Inc | $14.51 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139383442 | CMS |
| Dexcom, Inc. | $18.73 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153289478 | CMS |
| Exact Sciences Corporation | $14.96 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114631607 | CMS |
| Exact Sciences Corporation | $17.30 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114631612 | CMS |
| GENZYME CORPORATION | $24.27 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139668920 | CMS |
| GlaxoSmithKline, LLC. | $14.81 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116328150 | CMS |
| GlaxoSmithKline, LLC. | $18.39 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116716009 | CMS |
| Lilly USA, LLC | $19.31 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136083160 | CMS |
| Novo Nordisk Inc | $19.36 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096569986 | CMS |
| PFIZER INC. | $19.85 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131223354 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.